Enteric fever, commonly known as typhoid fever, is a systemic infection caused by Salmonella Typhi or Paratyphi. Despite advancements in diagnostic methods and treatment, it remains a significant global health issue, particularly in low-resource settings. This article aims to provide a comprehensive guide for healthcare professionals to optimize diagnosis and treatment strategies for enteric fever.
Diagnosing enteric fever can be challenging due to its nonspecific symptoms and the limitations of current diagnostic tests. Blood culture, the gold standard for diagnosis, has a sensitivity of only 40-60%. There is a pressing need for improved diagnostic tools that are both accurate and practical for use in resource-limited settings.
Recent advancements have led to the development of rapid diagnostic tests (RDTs), which offer promising results. These tests, based on the detection of specific antigens or antibodies, provide results within hours. However, more research is needed to establish their reliability and cost-effectiveness.
The mainstay of treatment for enteric fever is antibiotic therapy. However, the emergence of multi-drug resistant (MDR) strains has complicated treatment strategies. Fluoroquinolones have been the drugs of choice, but resistance to these is increasing, necessitating the use of third-generation cephalosporins or azithromycin.
With the rising trend of antibiotic resistance, the future lies in vaccine development. Current vaccines have limitations, but new-generation vaccines are under development. In addition, novel therapeutic strategies, such as the use of bacteriophages, are being explored.
Optimizing the diagnosis and treatment of enteric fever requires a multifaceted approach, encompassing the development of improved diagnostic tools, effective treatment regimens, and preventive measures. By staying abreast of emerging strategies, healthcare professionals can play a crucial role in managing this global health issue.
1.
New drug combination shows good results in patients with HPV-negative head and neck cancer
2.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
3.
Asian Women With Breast Cancer Outlive White Peers
4.
What Comes After Cancer?
5.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
1.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
2.
Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine
3.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
4.
Endurance Training in Hematologic Disease: Current Perspectives and Clinical Implications
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Diagnosis and Management in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation